ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AGL vs FMS // EV/EBITDA & P/E VALUATION

agilon health inc. (NYSE) VS. Fresenius Medical Care AG American (NYSE) • 15-METRIC TALLY: AGL 1 — FMS 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGL VS. FMS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AGL FMS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 9.90% -44.90 FMS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 21.0x — TIE /valuation <GO>
Free Cash Flow Yield -8.25% 2.21% -10.46 FMS /fcf-yield <GO>
Operating Margin -7.80% 13.90% -21.70 FMS /operating-margins <GO>
Net Profit Margin -6.60% 10.90% -17.50 FMS /net-margins <GO>
Revenue Growth (YoY) -2.10% -3.30% +1.20 AGL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.06 3.74 -1.68 FMS /balance-sheet <GO>
Piotroski F-Score Quality 3/9 7/9 -4.00 FMS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.4 50.8 -6.40 FMS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.90 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 30.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.43B $12.55B -$11.13B FMS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AGL REV FMS REV AGL GROSS % FMS GROSS % AGL FCF FMS FCF
FY 2025 $5.93B — — — -$119.0M —
FY 2024 $6.06B — — — -$71.0M —
FY 2023 $4.32B — — — -$156.2M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGL // BETA —
FMS // BETA 0.90